Clinical Trial Update: Tolerability and Lipid Lowering Effect of Weekly/Biweekly Crestor in Statin Intolerant Patients Treated With Zetia [Phase 4]

View source ↗

Summary

This Phase 4 trial update assesses tolerability and lipid-lowering effects of weekly or biweekly rosuvastatin in statin-intolerant patients treated with ezetimi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Zetia (ezetimibe)

Snippet

Sponsor: Bronx VA Medical Center | Conditions: Hypercholesterolemia | Phase 4 | Status: UNKNOWN